Xencor reported $835.27M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Amgen AMGN:US USD 63.7B 4.41B
Arrowhead Research ARWR:US USD 691.94M 59.84M
AstraZeneca AZN:LN USD 94.18B 2.39B
Biogen BIIB:US USD 24.85B 227.2M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Cytokinetics CYTK:US USD 1.08B 304.24M
GlaxoSmithKline GSK:LN GBP 60.31B 28.73B
Karyopharm Therapeutics KPTI:US USD 231.24M 25.24M
Macrogenics MGNX:US USD 195.35M 22.7M
Novartis NOVN:VX USD 118.46B 4.45B
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Seattle Genetics SGEN:US USD 3.62B 11.26M
Xencor XNCR:US USD 835.27M 16.06M